Read More
TT2020 Weizmann Institute of Science
Read More
16th TT Meeting, 25-28 October, 2020
Read More
Research The ISTT is involved in all levels of transgenic research in animals, from the animal technician to the senior scientist. This link will take you to our research page that includes relevant publications, CRISPR/Cas9 resources and news pertaining to transgenic technology. Training The ISTT sponsors meetings, workshops and training courses in transgenic technology. One of our most popular offerings is the Transgenic Technology (TT) meeting. To see the latest offerings, and to see how to apply for ISTT sponsorship of your training opportunity, please click here. Sponsor The ISTT is very grateful to our generous sponsors who provide us with support to continue our work. ISTT sponsors offer valuable goods and services necessary for transgenic technologies. The resources provided to the ISTT allow us to host the TT meetings, provide awards for our members, and assist with website support. Please visit our sponsors’ page.
ISTT MEMBERS HAVE ACCESS
TO EXCLUSIVE INFORMATION AND
RESOURCES WORLDWIDE.
Learn More Today

Already a Member?

Login Here

13th ISTT Prize to be awarded to Dr. Alexandra Joyner

The International Society for Transgenic Technologies (ISTT, Inc.) is delighted to announce that the 13th ISTT Prize will be awarded to Dr. Alexandra Joyner for her pioneering work on homologous recombination in embryonic stem cells. The ISTT Prize is awarded to investigators who have made outstanding contributions to the field of transgenic technologies. The selection of Dr. Joyner as the 13th ISTT Prize winner was made by the ISTT Prize Committee, composed of previous ISTT prize awardees, the ISTT President, (Wojtek Auerbach), the ISTT Vice-president, (Benoit Kanzler), and the CEO of genOway (Alexandre Fraichard) . GenOway generously sponsors this prestigious award.

Read More

Latest News

The ISTT responds to the ECJ Ruling that CRISPR/Cas9 should be regulated as GMO

Published Wednesday, August 15, 2018

The Board of Directors of the International Society for Transgenic Technology (ISTT) has the following comment on the ruling of the European Court of Justice (ECJ), which requires any that genome-edited organism shall be treated as GMO within the meaning of the European GMO Directive.

The ISTT, a scientific society representing the largest group of experts in the field of genome modification in animals, is surprised and disappointed that the court decided to focus on the method and not the product of genome editing and thus did not follow the recommendation of the court's Advocate General.

CRISPR Gene Editing of Human Embryos

Published Friday, August 4, 2017

In a collaborative effort of USA, South Korean and Chinese laboratories, the authors describe the correction of a mutation in the MYBPC3 gene associated with hypertrophic cardiomyopathy, through gene-editing, using CRISPR tools. (Nature article detailing results).

View All News

Upcoming Events

View All Events